DavidFitzgeraldArcherMD

Obstetrics & Gynecology • Norfolk, VA

Reproductive Endocrinology & Infertility

Professor, Obstetrics & Gynecology, Eastern Virginia Medical School

Join to view full profile

Are you Dr. Archer?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
You already have 34 invites waiting!
Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

Office
601 Colley Ave
Norfolk, VA 23507
Phone+1 757-446-7100

Fax+1 757-446-7455

Summary

Dr. David Archer, MD is an obstetrician/gynecologist in Norfolk, Virginia. He is currently licensed to practice medicine in Virginia and Pennsylvania. He is affiliated with Sentara Norfolk General Hospital and is a Professor at Eastern Virginia Medical School.

Education & Training

University of Louisville School of MedicineResidency, Obstetrics and Gynecology, 1963 - 1966
University of Louisville School of MedicineResidency, Obstetrics and Gynecology, 1961 - 1961
University of Louisville School of MedicineInternship, Transitional Year, 1960 - 1961
University of Louisville School of MedicineClass of 1960

Certifications & Licensure

VA State Medical License 1987 - 2026
PA State Medical License 1967 - 2014
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
American Board of Obstetrics and Gynecology Reproductive Endocrinology/Infertility

Awards, Honors, & Recognition

Fellow (FACOG) American Congress of Obstetricians and Gynecologists

Clinical Trials

Norplant and Irregular Bleeding/Spotting Start of enrollment: 2003 Feb 01
Unknown status
Phase 4
Contraceptive Effectiveness and Safety of the SILCS Diaphragm Start of enrollment: 2008 Jan 01
Completed
Phase 2, Phase 3
Residence Time of Biomarkers of Semen Exposure Start of enrollment: 2008 Dec 01
Completed
PK of Depo SubQ Injected in the Upper Arm Start of enrollment: 2010 May 01
Completed
Not Applicable
DHEA Against Vaginal Atrophy - Safety Study of 12 Months Start of enrollment: 2010 Dec 01
Completed
Phase 3
DHEA Against Vaginal Atrophy - 3-Month Efficacy Study Start of enrollment: 2010 Dec 01
Completed
Phase 3
Dehydroepiandrosterone (DHEA) Against Vaginal Atrophy Start of enrollment: 2011 Jun 01
Completed
Phase 3
Topical DHEA Against Vaginal Atrophy Start of enrollment: 2007 Jun 01
Completed
Phase 3
Efficacy Study of Two Continuous Regimens of Oral Daily 5 mg or 10 mg of Ulipristal Acetate (UPA), Versus a Dose of 5.0mg UPA for 24/4 Days Start of enrollment: 2014 Mar 01
Completed
Phase 2
Effect of Oral Estradiol and Progesterone Therapy on Vaginal Cytokines in Postmenopausal Women Start of enrollment: 2015 Dec 01
Completed
Phase 3
Effect of Intravaginal Prasterone on Symptoms of VVA in Women Under Treatment With an Aromatase Inhibitor for Breast Cancer Start of enrollment: 2018 Nov 06
Withdrawn
Phase 3
Join now to see all

Publications & Presentations

PubMed

Prostaglandin Eregulates the plasminogen activator pathway in human endometrial endothelial cells: a new in vitro model to investigate heavy menstrual bleeding.
Seifeldin Sadek, Terry A Jacot, Diane M Duffy, David F Archer
F&S Science. 2024-11-01
1 citations
Use of serum evaluation of contraceptive and ovarian hormones to assess reduced risk of pregnancy among women presenting for emergency contraception in a multicenter c...
Jeffrey T Jensen, Alison Edelman, Carolyn L Westhoff, Coutney A Schreiber, David F Archer
Contraception. 2024-09-01
3 citations
Emergency contraception for individuals weighing 80 kg or greater: A randomized trial of 30 mg ulipristal acetate and 1.5 mg or 3.0 mg levonorgestrel.
Alison Edelman, Jeffrey T Jensen, Jill Brown, Michael Thomas, David F Archer
Contraception. 2024-09-01

Press Mentions

First Approved Vaginal Contraceptive Ring for Year-Long Use Annovera Is Proven EffectiveMarch 26th, 2019
TherapeuticsMD Presents Positive Phase 3 Data in Two Presentations for TX-001HR at ENDO 2017April 3rd, 2017
TherapeuticsMD Presents Detailed Results from Phase 3 Rejoice Trial in Postmenopausal Women with Vulvar and Vaginal Atrophy (VVA) at ENDO 2016April 2nd, 2016

Grant Support

Doxycycline For Bleeding In Progestin Only ContraceptorsEunice Kennedy Shriver National Institute Of Child Health &Human Development2002–2006

Professional Memberships

American College of Obstetricians and Gynecologists
Fellow